March 20, 2025 -- More people are likely to be diagnosed with a condition that heightens the risk of heart attack and stroke, thanks to a controversial broadening of the definition that has ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

Chinese researchers say they have developed a “cocktail” nanovaccine to prevent plaque from building up in the arteries – an underlying factor in heart disease, which is the leading cause of ...